Fred Hutchinson Cancer Center
Clinical trials sponsored by Fred Hutchinson Cancer Center, explained in plain language.
-
Can a new drug stop transplant rejection in blood cancer patients?
Disease control OngoingThis study tests whether the drug ustekinumab can prevent acute graft-versus-host disease (GVHD) in adults with blood cancers who receive a stem cell transplant from an unrelated donor. GVHD occurs when donor cells attack the patient's body. The trial involves 116 participants an…
Phase: PHASE2 • Sponsor: Fred Hutchinson Cancer Center • Aim: Disease control
Last updated May 01, 2026 16:00 UTC
-
Smart bomb for blood cancer: targeted therapy combo shows promise in early trial
Disease control OngoingThis early-phase study tests a new targeted drug (PVEK) combined with standard chemotherapy for adults with aggressive, hard-to-treat blood cancers like acute myeloid leukemia (AML). The drug homes in on a marker found on cancer cells to deliver chemotherapy directly. The goal is…
Phase: PHASE1 • Sponsor: Fred Hutchinson Cancer Center • Aim: Disease control
Last updated Apr 30, 2026 15:51 UTC
-
Could a stem cell transplant stop immune attacks on the brain?
Disease control OngoingThis study tests a strong chemotherapy combination followed by a stem cell transplant to treat autoimmune neurologic diseases like multiple sclerosis and stiff person syndrome. The goal is to weaken the immune system so it stops attacking the nervous system. About 53 adults whose…
Phase: PHASE2 • Sponsor: Fred Hutchinson Cancer Center • Aim: Disease control
Last updated Apr 29, 2026 15:05 UTC
-
New drug aims to stop leukemia relapse after transplant
Disease control TerminatedThis early-stage trial tests a drug called DR-18 in 20 adults whose acute myeloid leukemia (AML) or myelodysplastic syndrome (MDS) has come back or persists after a stem cell transplant. DR-18 is designed to boost the body's immune system to fight cancer cells. The main goals are…
Phase: PHASE1 • Sponsor: Fred Hutchinson Cancer Center • Aim: Disease control
Last updated Apr 29, 2026 15:03 UTC
-
New study aims to improve cervical cancer detection for women with HIV
Diagnosis OngoingThis study looks at different screening methods to find early signs of cervical cancer in women living with HIV in the Dominican Republic. The goal is to see which approach—like testing for HPV—works best to catch precancerous changes early. About 619 women aged 25 to 49 will tak…
Phase: NA • Sponsor: Fred Hutchinson Cancer Center • Aim: Diagnosis
Last updated May 01, 2026 16:01 UTC
-
New program brings HIV testing to nightlife spots and offers text support to help men in peru get tested and linked to care
Prevention OngoingThis study tests a program designed to help men who have sex with men in Lima, Peru get tested for HIV and connect to treatment or prevention services. The program offers HIV testing at popular social venues and provides a text-messaging app with health information and support fr…
Phase: NA • Sponsor: Fred Hutchinson Cancer Center • Aim: Prevention
Last updated Apr 30, 2026 15:51 UTC
-
Poop pills may shield stem cell patients from deadly complication
Prevention OngoingThis study tests whether giving patients processed fecal material (fecal microbiota transplantation) after a stem cell transplant can prevent severe graft-versus-host disease (GVHD), a serious complication where donor cells attack the patient's body. The trial involves 138 adults…
Phase: PHASE2 • Sponsor: Fred Hutchinson Cancer Center • Aim: Prevention
Last updated Apr 29, 2026 15:03 UTC
-
New hope for ovarian cancer: coping program aims to ease despair
Symptom relief TerminatedThis study tests a program called HOPE that helps women with recurrent ovarian cancer cope with feelings of hopelessness and helplessness. About 60 participants will either take part in the HOPE workshops or receive usual care. The goal is to see if the program improves mental he…
Phase: NA • Sponsor: Fred Hutchinson Cancer Center • Aim: Symptom relief
Last updated May 01, 2026 15:59 UTC
-
New study aims to get cancer survivors moving
Symptom relief OngoingThis study tests whether a personalized program can help cancer survivors become more physically active and improve their diet. It involves 374 adult survivors of childhood or young adult cancers who are not very active. The program uses coaching, mobile apps, and goal-setting to…
Phase: NA • Sponsor: Fred Hutchinson Cancer Center • Aim: Symptom relief
Last updated May 01, 2026 15:59 UTC
-
Can a digital kitchen program help breast cancer survivors eat healthier?
Symptom relief OngoingThis study tests a program called MIND that delivers nutrition and cooking lessons online to breast cancer survivors. The goal is to see if it helps improve diet quality and increase fruit and vegetable intake. About 49 people with stage I-III breast cancer will participate, and …
Phase: NA • Sponsor: Fred Hutchinson Cancer Center • Aim: Symptom relief
Last updated Apr 30, 2026 15:51 UTC
-
LGBTQ+ smoking cessation app study pulled before start
Symptom relief TerminatedThis study aimed to test a smartphone app called EQQUAL-NM, designed to help LGBTQ+ young adults (ages 18-30) in New Mexico quit smoking. The app used a culturally-tailored avatar to guide users. However, the study was withdrawn before enrolling any participants, so no results ar…
Phase: NA • Sponsor: Fred Hutchinson Cancer Center • Aim: Symptom relief
Last updated Apr 30, 2026 15:50 UTC
-
New guidelines put to the test in chronic GVHD study
Knowledge-focused OngoingThis study looks at whether new guidelines from the National Institutes of Health can help doctors better diagnose and track chronic graft-versus-host disease (GVHD), a common complication after stem cell transplants. Researchers are following 601 patients over several years, col…
Sponsor: Fred Hutchinson Cancer Center • Aim: Knowledge-focused
Last updated Apr 30, 2026 15:51 UTC
-
New tools to track graft vs host disease treatment success
Knowledge-focused OngoingThis study involves 383 people with chronic Graft-versus-Host Disease (GVHD), a complication after stem cell transplant. Researchers are developing and testing new measurement tools to better determine if treatments are working. The goal is to create more accurate ways to assess …
Sponsor: Fred Hutchinson Cancer Center • Aim: Knowledge-focused
Last updated Apr 29, 2026 15:02 UTC